Clinical Trials Directory

Trials / Completed

CompletedNCT04834726

COVID-19 Vaccine Text Outreach

Pragmatic Trial of COVID Vaccine Text Outreach Interventions

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
19,554 (actual)
Sponsor
University of Pennsylvania · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

This project aims to evaluate different approaches to increase COVID-19 vaccine uptake among at-risk patients at Penn Medicine in an equitable and systematic manner through a centralized outreach program. The investigators will evaluate different text-based scheduling and messaging approaches informed by behavioral science to increase uptake among eligible patients, including the use of clinician endorsement, opt-out framing, and scarcity.

Detailed description

This project will evaluate a centralized approach to increasing COVID through direct outreach to eligible patients via text messaging. This pragmatic randomized controlled trial has the following aims: Aim 1: To conduct systematic large scale text message outreach for vaccine delivery among a defined group of Penn Medicine in a way that advances equity. Aim 2: To offer different scheduling workflows through text messaging that might increase uptake and reduce disparities. Aim 3: To compare the equity and efficiency of different messages informed by behavioral science, including PCP endorsement, opt-out framing, and scarcity.

Conditions

Interventions

TypeNameDescription
BEHAVIORALOpt-In (Call-Back)Messaging will include a prompt to agree to scheduling. If patient agrees, the access center will call these patients back to schedule, calling up to 3 times.
BEHAVIORALOpt-in (In-Bound)Messaging will include a prompt to agree to scheduling followed by a prompt to call the Penn Medicine Vaccine Scheduling Hotline to schedule their vaccine appointment.
BEHAVIORALStandard MessageThe message describes that the patient is eligible for the COVID vaccine.
BEHAVIORALClinician EndorsementThe message will describe an endorsement from the provider to get the vaccination.
BEHAVIORALScarcityThe message will highlight the limited availability and the elevated priority for the patient to receive the vaccine at Penn Medicine.
BEHAVIORALOpt-Out FramingThis will highlight that a vaccine is reserved for the patient, implying that they need to opt-out.
BEHAVIORALPhone CallThe access center will call these patients to schedule their vaccine appointment. These patients will not receive text messaging.

Timeline

Start date
2021-04-29
Primary completion
2021-06-04
Completion
2021-07-06
First posted
2021-04-08
Last updated
2023-03-27
Results posted
2023-03-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04834726. Inclusion in this directory is not an endorsement.